SCHEMBL5409583

SCHEMBL5409583

CCOC(=O)CNC(CCC(=O)OC(C)(C)C)C(=O)OCC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.51
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
HTT P42858 1/20 0.49
KMT2A Q03164 2/20 0.49
POLB P06746 1/20 0.49
GAA P10253 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
CTSK P43235 2/20 0.38
ALDH1A1 P00352 5/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MGAM O43451 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
MAPT P10636 2/20 0.36
TSHR P16473 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21271460 0.88 L3MBTL1 (0.65) L3MBTL1CYP1A2CYP2C9CYP2C19HTT
SCHEMBL21271462 0.88 L3MBTL1 (0.65) L3MBTL1CYP1A2CYP2C9CYP2C19HTT
SCHEMBL21271459 0.88 L3MBTL1 (0.65) L3MBTL1CYP1A2CYP2C9CYP2C19HTT
SCHEMBL3175852 0.82 CYP1A2 (0.49) L3MBTL1CYP1A2CYP2C9CYP2C19HTT
SCHEMBL5330001 0.81 L3MBTL1 (0.53) L3MBTL1CYP1A2CYP2C9CYP2C19HTT
SCHEMBL24660086 0.79 L3MBTL1 (0.48) L3MBTL1CYP1A2CYP2C9CYP2C19HTT
SCHEMBL7428145 0.79 CA12 (0.37) L3MBTL1CYP1A2CYP2C9CYP2C19HTT
SCHEMBL7434264 0.79 CA12 (0.37) L3MBTL1CYP1A2CYP2C9CYP2C19HTT
SCHEMBL2721298 0.78 CYP1A2 (0.68) L3MBTL1CYP1A2CYP2C9CYP2C19HTT
SCHEMBL2721300 0.78 CYP1A2 (0.68) L3MBTL1CYP1A2CYP2C9CYP2C19HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7175767-B2 Preparation of a metal chelating separation medium GE HEALTHCARE BIO-SCIENCES AB (SE) 2007-02-13 US disclosed
US-20060199950-A1 Preparation of a metal chelating separation medium GE HEALTHCARE BIO-SCIENCES AB (SE) 2006-09-07 US disclosed
WO-2004087284-A1 PREPARATION OF A METAL CHELATING SEPARATION MEDIUM AMERSHAM BIOSCIENCES AB (SE) 2004-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060199950-A1 Preparation of a metal chelating separation medium CA1, CA3, CA12 L3MBTL1 3959/4885CYP1A2 2781/4885CYP2C9 3575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.